J I Geh

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

T. Crosby, Stephen Falk, Simon Gollins et al. · The Lancet Oncology · 2013 · 381 citations · Full text

Medicine, Oncology, Surgery +17

Chemoradiotherapy for Rectal Cancer: An Updated Analysis of Factors Affecting Pathological Response

Paul Sanghera, Douglas W. Wong, Christopher C. McConkey et al. · Clinical Oncology · 2008 · 182 citations

Medicine, Oncology, Radiation Oncology +14

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer

Syed A. Hussain, Deborah Stocken, Peter Riley et al. · British Journal of Cancer · 2004 · 102 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer

Tom Crosby, Chris Hurt, Stephen Falk et al. · British Journal of Cancer · 2017 · 79 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancer

Christopher J. Smart, Stephan Körsgen, J. Hill et al. · British journal of surgery · 2016 · 69 citations

Medicine, Oncology, Surgery +17